BlackRock Fund Advisors’s Traws Pharma TRAW Stock Holding History

BlackRock Fund Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Hold	0	–	–	–	4208
2016 Q3	–	Hold	0	–	–	–	4235
2016 Q2	–	Sell	-1	Closed	-$28.1K	–	4183
2016 Q1	$20K	Hold	1	–	–	﹤0.01%	3903
2015 Q4	$35K	Hold	1	–	–	﹤0.01%	3922
2015 Q3	$46K	Hold	1	–	–	﹤0.01%	3840
2015 Q2	$82K	Hold	1	–	–	﹤0.01%	3765
2015 Q1	$73K	Buy	+1	New	+$164K	﹤0.01%	3663
2014 Q4	–	Sell	-5	Closed	-$1.22M	–	3636
2014 Q3	$1.25M	Hold	5	–	–	﹤0.01%	3177
2014 Q2	$1.49M	Sell	5 -3	-38%	-$885K	﹤0.01%	3142
2014 Q1	$2.74M	Buy	8 +1	+14%	+$602K	﹤0.01%	3089
2013 Q4	$4.71M	Buy	7 +4	+133%	+$3.79M	﹤0.01%	2860
2013 Q3	$4.43M	Buy	+3	New	+$4.29M	﹤0.01%	2898

Other funds holding TRAW

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Fund Advisors's TRAW Position: Q4 2016 in Review

BlackRock Fund Advisors held its Traws Pharma (TRAW) position steady in Q4 2016 at 0 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #4208.

BlackRock Fund Advisors first reported a position in TRAW in Q3 2013 and has held it in 10 quarters since. The position peaked at $4.71M in Q4 2013. 10 funds tracked by Wall St. Rank hold TRAW as of Q4 2016.

BlackRock Fund Advisors held 0 shares of Traws Pharma worth $1K as of Q4 2016.
BlackRock Fund Advisors left its Traws Pharma share count unchanged in Q4 2016.
Traws Pharma made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4208 holding.
BlackRock Fund Advisors first reported a position in Traws Pharma in Q3 2013 and has held it in 10 quarters since.
BlackRock Fund Advisors's Traws Pharma position peaked at $4.71M in Q4 2013.
10 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.